Clinical trial
A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
NCT00195845 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
- Lead sponsor
- Cambridge Health Alliance
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- February 28, 2007
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.